Repaglinide



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 34.2%
Type 2 Diabetes Mellitus 31.6%
Diabetes Mellitus 14.7%
Drug Use For Unknown Indication 2.7%
Hypertension 1.8%
Insulin-requiring Type 2 Diabetes Mellitus 1.8%
Atrial Fibrillation 1.3%
Dyslipidaemia 1.3%
Dyspnoea 1.3%
Hyperuricaemia 1.3%
Pyrexia 1.3%
Rhinitis 1.3%
Cardiac Failure 0.9%
Cerebral Infarction 0.9%
Radiation Oesophagitis 0.9%
Type 1 Diabetes Mellitus 0.9%
Angina Pectoris 0.4%
Blood Glucose Increased 0.4%
Bronchitis 0.4%
Cardiac Disorder 0.4%
Hypoglycaemia 13.1%
Hypoglycaemic Coma 13.1%
Sopor 9.8%
Acute Generalised Exanthematous Pustulosis 4.9%
Cytolytic Hepatitis 4.9%
Eosinophilia 4.9%
Hyperkalaemia 4.9%
Malaise 4.9%
Pruritus 4.9%
Rash 4.9%
Abdominal Pain 3.3%
Acute Hepatic Failure 3.3%
Cholestasis 3.3%
Diarrhoea 3.3%
Drug Intolerance 3.3%
Nephropathy 3.3%
Pulmonary Alveolar Haemorrhage 3.3%
Renal Failure 3.3%
Bladder Cancer 1.6%
Bladder Neoplasm 1.6%
Secondary
Product Used For Unknown Indication 21.7%
Type 2 Diabetes Mellitus 21.2%
Diabetes Mellitus 20.7%
Hypertension 10.7%
Drug Use For Unknown Indication 7.9%
Haemolytic Uraemic Syndrome 2.7%
Bipolar Disorder 2.1%
Cardiac Failure 2.0%
Ill-defined Disorder 1.4%
Rheumatoid Arthritis 1.3%
Atrial Fibrillation 1.2%
Dyslipidaemia 1.2%
Hypothyroidism 1.1%
Premedication 1.1%
Pain 0.8%
Coronary Artery Disease 0.7%
Dementia Alzheimer's Type 0.6%
Hyperuricaemia 0.6%
Infection 0.6%
Benign Prostatic Hyperplasia 0.5%
Hypoglycaemia 24.4%
Thrombocytopenia 6.5%
Malaise 5.7%
Renal Failure 5.7%
Vomiting 5.7%
Hypoglycaemic Coma 4.9%
Pancreatic Carcinoma Metastatic 4.1%
Renal Failure Acute 4.1%
Colitis 3.3%
Dizziness 3.3%
Drug Interaction 3.3%
Hepatic Cirrhosis 3.3%
Hepatitis 3.3%
Interstitial Lung Disease 3.3%
Leukocytoclastic Vasculitis 3.3%
Medication Error 3.3%
Myoclonus 3.3%
Nephropathy 3.3%
Pancreatitis Acute 3.3%
Respiratory Failure 3.3%
Concomitant
Product Used For Unknown Indication 23.5%
Drug Use For Unknown Indication 15.9%
Type 2 Diabetes Mellitus 14.9%
Hypertension 13.3%
Diabetes Mellitus 11.8%
Atrial Fibrillation 2.2%
Pain 2.2%
Prophylaxis 2.2%
Rheumatoid Arthritis 1.8%
Hypercholesterolaemia 1.7%
Coronary Artery Disease 1.3%
Dyslipidaemia 1.3%
Bronchitis 1.1%
Myocardial Infarction 1.1%
Depression 1.1%
Back Pain 1.0%
Hepatitis C 0.9%
Hypothyroidism 0.9%
Thrombosis Prophylaxis 0.9%
Multiple Myeloma 0.8%
Renal Failure Acute 14.3%
Vomiting 8.9%
Colon Cancer Recurrent 5.7%
Diabetes Mellitus Inadequate Control 5.7%
Death 5.4%
Thrombocytopenia 5.0%
Weight Increased 5.0%
Drug Interaction 4.6%
Renal Failure 4.6%
Anaemia 4.3%
General Physical Health Deterioration 3.9%
Lactic Acidosis 3.9%
Lung Disorder 3.9%
Pulmonary Embolism 3.9%
Hyperglycaemia 3.6%
Metastases To Liver 3.6%
Urinary Tract Infection 3.6%
Weight Decreased 3.6%
Hypoglycaemia 3.2%
International Normalised Ratio Increased 3.2%
Interacting
Type 2 Diabetes Mellitus 25.5%
Prostate Cancer Metastatic 15.7%
Hypertension 10.8%
Helicobacter Infection 5.9%
Drug Use For Unknown Indication 4.9%
Product Used For Unknown Indication 4.9%
Diabetes Mellitus 3.9%
Hormone Therapy 3.9%
Pain 3.9%
Osteomyelitis 2.9%
Atrial Fibrillation 2.0%
Bacterial Infection 2.0%
Dyslipidaemia 2.0%
Osteitis 2.0%
Osteoporosis 2.0%
Prophylaxis Against Gastrointestinal Ulcer 2.0%
Restless Legs Syndrome 2.0%
Secondary Hyperthyroidism 2.0%
Depression 1.0%
Gastrooesophageal Reflux Disease 1.0%
Hypoglycaemia 42.1%
Hypoglycaemic Coma 21.1%
Transaminases Increased 10.5%
Drug Interaction 5.3%
Drug Level Fluctuating 5.3%
Myoclonus 5.3%
Oedema Peripheral 5.3%
Thrombocytopenia 5.3%